Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-30.15%
operating margin TTM
-27.53%
revenue TTM
1.53 Billion
revenue per share TTM
19.68$
valuation ratios | |
|---|---|
| pe ratio | -1.71 |
| peg ratio | -1.60 |
| price to book ratio | 0.82 |
| price to sales ratio | 0.52 |
| enterprise value multiple | 2.92 |
| price fair value | 0.82 |
profitability ratios | |
|---|---|
| gross profit margin | 53.5% |
| operating profit margin | -27.53% |
| pretax profit margin | -33.19% |
| net profit margin | -30.15% |
| return on assets | -13.58% |
| return on equity | -38.51% |
| return on capital employed | -13.78% |
liquidity ratios | |
|---|---|
| current ratio | 3.14 |
| quick ratio | 1.80 |
| cash ratio | 0.64 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 233.66 |
| operating cycle | 291.90 |
| days of payables outstanding | 44.10 |
| cash conversion cycle | 247.81 |
| receivables turnover | 6.27 |
| payables turnover | 8.28 |
| inventory turnover | 1.56 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.55 |
| debt equity ratio | 1.93 |
| long term debt to capitalization | 0.63 |
| total debt to capitalization | 0.66 |
| interest coverage | -5.45 |
| cash flow to debt ratio | 0.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.19 |
| cash per share | 3.49 |
| operating cash flow per share | 1.16 |
| free cash flow operating cash flow ratio | -0.16 |
| cash flow coverage ratios | 0.04 |
| short term coverage ratios | 2.30 |
| capital expenditure coverage ratio | 0.86 |
Frequently Asked Questions
When was the last time Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported earnings?
Integra LifeSciences Holdings Corporation (IART) published its most recent earnings results on 30-10-2025.
What is Integra LifeSciences Holdings Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Integra LifeSciences Holdings Corporation (NASDAQ:IART)'s trailing twelve months ROE is -38.51%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Integra LifeSciences Holdings Corporation (IART) currently has a ROA of -13.58%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IART's net profit margin stand at?
IART reported a profit margin of -30.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IART's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.14 in the most recent quarter. The quick ratio stood at 1.80, with a Debt/Eq ratio of 1.93.